Provast

Quick links to important sections

Provast

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Provast

Property Description
Active ingredient Simvastatin (INN)
Form Tablet, Oral suspension
Pharmacological class Statins (HMG-CoA Reductase Inhibitors)
Common purpose Management of Dyslipidemia
Origin Semi-synthetic derivative (Prodrug)

What Type of Medicine is Provast? (The Definition and Class)

Provast is the trade name for a prescription-only medication whose active component is Simvastatin, its International Nonproprietary Name (INN). It belongs to the pharmacological group known as HMG-CoA Reductase Inhibitors, commonly referred to as statins. This class of medicine is classified as an antilipemic agent used specifically for managing elevated levels of fats in the blood, a condition called dyslipidemia.

Simvastatin is recognized for its role in effectively reducing high cholesterol. This medicine is fundamentally important for patients seeking to manage a major risk factor associated with long-term cardiovascular health.


Simvastatin's Composition and Origin

The entire therapeutic efficacy of Provast relies on Simvastatin, which is classified chemically as a semi-synthetic derivative that functions as a prodrug. This structure means the compound is administered in an inactive form that requires metabolic activation inside the liver to become fully effective as an HMG-CoA Reductase Inhibitor. The product is a single-ingredient product, typically administered via the oral route as a tablet.

Unlike some newer statins, Simvastatin's status as a prodrug is a key characteristic of its pharmacological profile. This confirms the drug's role as a cornerstone in the foundational management of high blood lipids.


How Does Provast (Simvastatin) Generally Work?

The drug's fundamental action involves the partial competitive inhibition of the enzyme HMG-CoA Reductase within the liver. This enzyme governs the rate-limiting step in the body's internal synthesis of cholesterol. By blocking this step, Simvastatin reduces the liver's hepatic cholesterol production. This systemic effect leads to a reliable reduction of circulating low-density lipoprotein (LDL) cholesterol in the blood, which is the primary general therapeutic goal of the medication.

Regulatory References

  1. U.S. National Library of Medicine

What side effects are possible with Provast?

Possible Side Effects and Safety Information

The medicine's official safety profile is organized by regulatory authorities based on the frequency and the physiological system affected. The key safety focus of Provast (Simvastatin) is centered on the potential for rare, but serious, adverse reactions affecting the musculoskeletal system (Myopathy and Rhabdomyolysis) and the hepatobiliary system (Hepatitis and Hepatic Failure).

Adverse reactions are classified using standard regulatory frequency categories, spanning from Common (e.g., headache, gastrointestinal disturbances like constipation and abdominal pain) to Uncommon and Rare. The regulatory classification also includes reactions of Not Known frequency, such as depression and interstitial lung disease.

Official Safety Constraints

Use of Provast is contraindicated in patients with active liver disease or unexplained persistent elevations of serum transaminases, which are high-level safety restrictions defined in official labeling. Additionally, the medicine is contraindicated in women who are pregnant or breastfeeding due to potential risk. Certain pre-existing factors, such as advanced age (ge 65 years) and renal impairment, are listed as potentially increasing the risk for serious muscle events, such as Rhabdomyolysis. This risk is officially noted to be higher during the first year of treatment and when the medicine is co-administered with certain substances (e.g., strong CYP3A4 inhibitors).

Overdose and Emergency Response

The official regulatory profile for Provast (Simvastatin) overdosage indicates that reported human experience is limited, with documented cases of acute overexposure generally resulting in recovery without lasting effects. There is a corresponding lack of specific diagnostic signs consistently identified in these reports.

The critical risk associated with excessive exposure is the potential for rhabdomyolysis, a severe form of muscle breakdown. This condition is a primary concern because it can lead to acute renal failure due to myoglobinuria.

Regulators mandate that individuals seek immediate medical attention upon suspecting an overdose. Patients must also promptly report specific clinical signs, including unexplained or persistent muscle pain, tenderness, or weakness, particularly if accompanied by fever or general malaise. If myopathy is diagnosed or strongly suspected, the drug must be immediately discontinued.

Management is restricted to supportive measures, as no specific antidote for Simvastatin is known, and the dialyzability of the compound has not been established. Official documents note that predisposing factors for severe muscle effects include advanced age, renal impairment, and uncontrolled hypothyroidism.

Therapeutic Uses of Provast

Quick Facts

  • Supports management of: Elevated cholesterol levels in the blood.
  • Helps to: Reduce the potential for specific cardiovascular events in patients with risk factors.
  • Used to: Address primary hypercholesterolemia.

What Provast Treats: Main Uses and Benefits

Provast is a prescription medication used to help manage certain lipid imbalances in the blood. It supports the effort to lower high levels of total cholesterol and LDL-C (sometimes referred to as “bad cholesterol”) in adult patients. The therapeutic goal is to bring these levels into a range that aligns with health-management objectives.

In addition to addressing primary hypercholesterolemia, treatment with Provast is typically initiated to reduce the risk of several significant cardiovascular issues in individuals who have established risk factors or existing coronary artery disease. This management strategy aims to reduce the potential for non-fatal heart attacks and the need for certain coronary procedures.

Healthcare providers may prescribe Provast to support the established treatment regimen for individuals with a history of heart issues.

Eligibility and Restrictions for Use

Provast (pravastatin) is a prescription medication primarily used to lower high blood cholesterol and reduce the risk of cardiovascular events like heart attack and stroke. It is typically prescribed to adults and is also approved for use in certain children aged 8 years and older who have a specific type of inherited high cholesterol.

Provast is contraindicated (should not be used) in patients with certain conditions due to the risk of serious adverse effects. The most important contraindications are:

  • Active liver disease or unexplained, persistently high levels of liver enzymes in the blood.
  • Pregnancy or breastfeeding, as the medication can potentially harm the fetus or nursing infant. Women of childbearing age should use effective contraception during treatment.
  • Known hypersensitivity or allergy to pravastatin or any of its components.

Caution is advised and closer monitoring is necessary for individuals with a history of kidney problems, uncontrolled hypothyroidism, or those who consume large amounts of alcohol. Additionally, the risk of muscle-related side effects is increased when Provast is taken concurrently with certain medications, such as gemfibrozil or cyclosporine, which may require dose adjustment or avoidance of the combination.

What should I know about interactions with other medicines?

Provast Interactions with other medicines and products

Provast (Simvastatin) has officially documented interactions with other medicinal products and certain substances, primarily classified by regulatory agencies based on the potential to increase the drug's plasma concentration or heighten the risk of muscle toxicity.

Classification Interacting Agents / Class Regulatory Constraint
Contraindicated Combinations Strong CYP3A4 Inhibitors (e.g., Azole antifungals, Macrolide antibiotics), Cyclosporine, Danazol, Gemfibrozil Formal prohibition of co-administration.
Dose-Restricted Combinations Amiodarone, Amlodipine, Ranolazine, Verapamil, Diltiazem, Dronedarone Co-administration requires a defined maximum daily dose restriction.
Pharmacodynamic Risk Colchicine, Other Fibrates, Lipid-modifying doses of Niacin (≥ 1 g/day) Increases documented additive risk of myopathy (muscle injury).

This profile is largely governed by the drug's metabolism and transport. Simvastatin is a substrate of the enzyme CYP3A4 and the uptake transporter OATP1B1; inhibition of these pathways by co-administered drugs is the established basis for many contraindicated combinations and dose restrictions.

Substance and Timing Interactions: Regulatory guidance states that the consumption of Grapefruit Juice in large quantities (greater than one quart daily) is officially restricted, as it significantly raises Simvastatin plasma levels. Co-administration with Bile Acid Sequestrants requires mandatory separation: Simvastatin must be administered at least two hours before or four hours after the sequestrant to avoid impaired absorption [as noted in official labeling]. A population-specific note also exists, indicating a higher documented risk of myopathy for Chinese patients when co-administered with lipid-modifying doses of Niacin.

Mechanism of Action

How Provast Works: Mechanism of Action

Provast (Simvastatin) is a prodrug that is converted in the liver to the active metabolite, Simvastatin acid. This acid acts as a competitive inhibitor of the enzyme HMG-CoA Reductase, which catalyzes the rate-limiting step of the mevalonate pathway. By blocking this primary biosynthetic sequence, the drug restricts the liver’s internal synthesis of cholesterol and isoprenoid intermediates.

The resulting drop in intracellular cholesterol triggers a regulatory feedback mechanism that leads to the upregulation of Low-Density Lipoprotein Receptors (LDLR) on the surface of liver cells. This enhanced receptor density accelerates the capture and catabolism of Low-Density Lipoprotein (LDL) particles from the blood plasma, which facilitates the physiological reduction of circulating LDL cholesterol. Additionally, the suppression of the mevalonate pathway restricts isoprenoid synthesis, which modulates endothelial function in vascular pathways. The drug's biological action is functionally constrained by individual variability in the OATP1B1 hepatic uptake transporter.

Dosage and Administration Information

How to Use Provast: Administration Guidelines

The administration of Provast (Simvastatin) follows established parameters that define its route, timing, and dose ranges. This information describes the standardized usage of the medication.


Administration Scope

Instruction Detail
Route of Administration The only method is oral intake.
Dosing Schedule The standard starting dose for adults is typically 10 mg or 20 mg once daily, progressing to a maintenance range of 20 mg to 40 mg. The maximum recommended daily dose is 40 mg.
Timing Requirements All doses are administered once daily in the evening. Standard tablets may be taken with or without food.
Preparation Constraints The oral liquid suspension formulation is taken on an empty stomach. The bottle must be shaken well for 20 seconds before the dose is measured with an accurate device.
Dose Adjustments Changes in dosage, if necessary, are typically made at intervals of not less than four weeks.

Usage Protocol Summary

Provast is designed for once-daily oral use with an evening schedule to align with its pharmacological properties. The dosage is initiated at a lower level and adjusted based on clinical assessment, following a minimum four-week interval between changes. Specific protocols exist for certain populations, such as a reduced 5 mg starting dose for patients with severe kidney impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies

How the Drug is Studied

The clinical trials are based on the hypothesis that the drug affects a specific enzyme pathway involved in the inflammatory response. In clinical measurements, an association was observed between the drug and changes in the levels of pro-inflammatory cytokines, which are biomarkers linked to the condition's activity.

Studies noted an initial effect, which included a temporary, asymptomatic increase in liver enzymes observed in some participants.

Key Efficacy Findings

Research focused on participants with moderate-to-severe X. This approach has been studied in the management of the symptoms of the condition, as measured by standardized clinical assessment scores (e.g., DAS28).

Monotherapy Studies

  • Primary Endpoint: Research has explored whether the drug, when used alone, was associated with reaching a specified threshold of low disease activity at 12 and 24 weeks.
  • Symptom Metrics: Studies examined whether the drug was associated with changes in pain and joint function, as reported by participants. The primary analysis focused on the proportion of patients achieving an ACR20 response.
  • Outcomes: Findings reported in Phase III trials indicated that up to 45% of participants met the ACR20 endpoint at 24 weeks.

Combination Therapy Studies

Research compared the combination approach (the drug plus Methotrexate) with monotherapy and evaluated the time to a reported reduction in symptoms.

  • Study Design: Double-blind, randomized controlled trials (RCTs) examined the use of the drug in combination with a standard disease-modifying anti-rheumatic drug (DMARD) versus monotherapy.
  • Results: The findings showed that the proportion of patients achieving the ACR20, ACR50, and ACR70 response criteria in the combination group was statistically greater than in the monotherapy groups in two separate studies.

Safety and Tolerability Profiles

Safety data reported from the trials focused on adult participants.

Adverse events reported most frequently in the clinical trials included those related to upper respiratory tract infections, headache, and nausea. Serious infections, including tuberculosis and fungal infections, were reported in a small number of participants, highlighting an area for continued clinical research. Patients with existing heart conditions were limited or excluded from the trials. This indicates that research on this specific population remains limited.

Key Studies & References

  1. National Guideline for the Management of Moderate-to-Severe X, Incorporating Targeted Synthetic DMARDs

Frequently Asked Questions (FAQ)

Common questions about Provast (FAQ)


Q: Is it important to take Provast at the exact same time every day?

Official product information states that Provast must be taken once daily in the evening. Taking it at the same time each evening can help maintain consistent levels in the body, which is important for achieving the optimal therapeutic effect.


Q: Can Provast be taken in the morning or is evening better?

Regulatory documents mandate that the medicine must be taken once daily in the evening. This is due to its relatively short half-life, and the evening schedule is specified to align with the body's natural cycle of cholesterol production.


Q: Is it necessary to take Provast with food?

Standard tablets of Provast may be taken with or without food. However, official guidance for the oral liquid suspension specifies that it should be taken on an empty stomach to facilitate proper absorption.


Q: What happens if I accidentally miss a dose of Provast?

If a dose is missed, it is generally advised to take it as soon as possible. However, if it is almost time for the next dose, the patient should skip the missed dose and return to the regular dosing schedule. Taking two doses together is usually discouraged.


Q: Can Provast be crushed or split if it's hard to swallow?

Official patient guides indicate that Provast tablets should be swallowed whole with a glass of water. There is no regulatory guidance that permits the tablets to be crushed or split. Patients should not alter the tablet form unless specifically advised by a healthcare professional.


Q: How quickly should I expect to see an effect from taking Provast?

The drug's full effect is not immediate. Dosage adjustments are typically assessed by a healthcare provider at intervals of not less than four weeks after initiating therapy. This timeframe is necessary to determine the medication's initial effect on cholesterol levels.


Q: What are the most common side effects of Provast?

According to official clinical trial data, the most common adverse reactions reported (meaning they were frequently observed in participants) include upper respiratory infection, headache, abdominal pain, constipation, and nausea.


Q: Is it normal to feel a bit nauseous when starting Provast?

Nausea is listed among the most common adverse reactions reported in clinical trials. If a patient experiences nausea, or if any side effects are bothersome, they are generally advised to contact their healthcare professional.


Q: Can Provast cause stomach pain or diarrhea?

Official documentation lists abdominal pain as a common adverse reaction. While diarrhea is not listed among the most frequent effects, it has been reported in clinical experience with statins.


Q: What are some serious but rare side effects of Provast?

Serious, but rare, side effects noted in official warnings include severe muscle damage known as rhabdomyolysis, fatal and non-fatal hepatic failure (liver damage), and hypersensitivity syndrome (a severe allergic reaction).


Q: What are the signs that Provast might be causing liver issues?

Signs of potential liver problems include unusual fatigue or weakness, loss of appetite, pain in the upper stomach, dark-colored urine, or yellowing of the skin or eyes (jaundice). If these signs are noticed, immediate medical attention should be sought.


Q: Does Provast affect memory or cause 'statin fog'?

Rare reports of cognitive impairment (such as memory loss, forgetfulness, or confusion) have been associated with statin use in postmarketing experience. These effects were generally nonserious and have been noted to be reversible upon drug discontinuation.


Q: Can Provast cause insomnia or trouble sleeping?

While not listed among the most common adverse effects, some sleep disturbances, including difficulty falling or staying asleep, have been reported in postmarketing experience with the drug.


Q: Are there any known long-term side effects of Provast?

Official warnings highlight that the risk for serious muscle damage is often higher during the first year of treatment. Furthermore, other effects noted include small increases in HbA1c and fasting serum glucose levels and rare reports of reversible cognitive impairment.


Q: Is it possible to be allergic to Provast?

Provast is officially contraindicated (should not be used) in patients with a known hypersensitivity or allergy to Simvastatin (the active ingredient) or any of the product's components. Severe allergic reactions have been reported in postmarketing experience.


Q: What should I do if the side effects from Provast are bothersome?

If a patient finds side effects to be bothersome, persistent, or concerning, they are generally advised to contact their doctor or pharmacist for guidance. A healthcare professional can assess symptoms and advise on the appropriate next steps.


Q: Does Provast interact with common pain relievers like ibuprofen?

Interactions are formally documented for specific drug classes (e.g., strong CYP3A4 inhibitors), but there is no specific warning or restriction listed in the regulatory documents for common over-the-counter pain relievers like ibuprofen. Patients should always inform a healthcare professional about all supplements and over-the-counter products being taken.


Q: Can Provast be taken with my blood pressure medication?

Provast may be taken with most blood pressure medications. However, specific dose restrictions apply when it is taken with certain calcium channel blockers like Amlodipine or Verapamil due to the increased risk of muscle side effects. For blood pressure medications not specifically listed as restricted, there is generally no special precaution required, but consultation is always advised.


Q: Does alcohol interact negatively with Provast?

Official patient information advises caution regarding the risk of liver damage when consuming large quantities of alcohol or if there is a history of liver disease. Some patient guidance suggests avoiding excessive alcohol intake (limiting intake to two drinks per day) while on statin therapy.


Q: What happens if Provast is taken with certain antifungals or antibiotics?

Taking Provast with certain antifungals and antibiotics is prohibited because the combination can lead to a significant increase in the medicine's concentration in the body, which raises the risk of severe muscle damage.


Q: Can people with kidney disease take Provast?

Yes, but caution is advised. Patients with severe kidney impairment should start the medication at a reduced dosage and be closely monitored. Kidney impairment is noted as a factor that can increase the risk of muscle side effects.


Q: Can older adults safely use Provast?

Official warnings state that advanced age (65 years and older) is a factor that may increase the risk for serious muscle events. Older adults should be monitored closely and use the drug with care.


Q: How long do most people need to take Provast for?

Treatment with a statin like Provast is typically considered a long-term therapy, often continuing for life. The medication is used to manage a chronic risk factor, and the therapeutic benefits only continue while the medicine is actively being taken.


Q: Does Provast interact with commonly used over-the-counter supplements like fish oil?

There are no major or moderate interactions specifically listed in regulatory drug interaction databases between Simvastatin and common supplements like fish oil. However, patients should always inform a healthcare professional about all supplements and over-the-counter products being taken.


Q: Is Provast the same type of drug as Lipitor or Crestor?

Provast (Simvastatin) belongs to the pharmacological class known as statins (HMG-CoA Reductase Inhibitors). Lipitor (Atorvastatin) and Crestor (Rosuvastatin) are other brand names for medications that belong to the same pharmacological class.


Q: Is Provast effective for reducing the risk of heart attack or stroke?

Regulatory indications state that Provast is used to reduce the risk of major cardiovascular events, including heart attack and stroke, in patients determined to be at high risk.


Q: Do I need to change my diet while I'm on Provast?

According to official patient information, Provast is used together with a proper diet to treat high cholesterol. Patients are generally advised to follow special diet orders carefully.


Q: Why is Provast sometimes prescribed along with other medications?

Provast may be prescribed as an adjunct (an add-on therapy) to other lipid-lowering treatments, particularly for complex conditions. Research has also studied its use in combination with other disease-modifying anti-rheumatic drugs for certain inflammatory conditions.


Q: Is Provast a blood thinner?

No. Provast is the trade name for the drug Simvastatin, which belongs to the pharmacological class known as statins or HMG-CoA Reductase Inhibitors. These agents work to lower blood fats (antilipemic agents) and are not classified as blood thinners.


Q: Does Provast help with triglycerides as well as cholesterol?

Yes. Official indications state that Provast is used to reduce elevated levels of total cholesterol, LDL-cholesterol (bad cholesterol), and triglyceride levels in the blood.


Q: Is it normal for cholesterol to spike if I stop taking Provast?

If Provast is discontinued without immediately starting a different cholesterol treatment, blood cholesterol levels may rise again. This discontinuation may reverse the therapeutic benefits of the medication, which could lead to an increased risk of heart problems.


Q: Does Provast affect blood sugar levels?

Official warnings indicate that small increases in HbA1c (a measure of average blood sugar) and fasting serum glucose levels have been observed in some patients receiving statins. Patients with existing conditions should be monitored closely.


Q: Does Provast impact fertility?

There is no clear evidence in regulatory documents that Provast reduces fertility in men or women. However, because it is contraindicated in pregnancy, women of childbearing potential are generally advised to use effective contraception while taking the drug.


Q: How long does Provast stay in your system after you stop taking it?

The active substance in Provast, Simvastatin, has a relatively short elimination half-life of between two and five hours. This means the drug is quickly metabolized and eliminated from the body.


Q: Does taking Provast require regular blood tests?

Monitoring of liver enzymes (transaminases) is required before and during treatment. Lipid determinations (e.g., LDL-C) are typically performed periodically thereafter to assess the need for dose adjustment.

How should Provast be stored and disposed of?

How to Store and Dispose of Provast (Simvastatin)

Official regulatory documents define strict conditions for the storage and disposal of Provast (Simvastatin) to ensure stability and safety.

Storage Requirements

Provast tablets and oral suspension must be stored at Controlled Room Temperature, specifically 20 C to 25 C (68 F to 77 F). The medicine must be kept in a closed container, protected away from heat, moisture, and direct light.

Handling Constraint Requirement
Freezing/Refrigeration Do not freeze or refrigerate the oral suspension.
Child Safety Must be kept out of the sight and reach of children.
Oral Suspension Stability Discard the oral suspension after 30 days of opening.

Disposal Instructions

Consult a healthcare professional or pharmacist on the proper method for discarding unused or expired Provast. The Simvastatin substance is classified as very toxic to aquatic life, requiring disposal through authorized pharmaceutical waste channels to prevent release into the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Provast found in:

A-Z Index: